» Articles » PMID: 9183006

The in Vitro Phosphorylation of P53 by Calcium-dependent Protein Kinase C--characterization of a Protein-kinase-C-binding Site on P53

Overview
Journal Eur J Biochem
Specialty Biochemistry
Date 1997 May 1
PMID 9183006
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

We show that, in vitro, Ca2+-dependent protein kinase C (PKC) phosphorylates recombinant murine p53 protein on several residues contained within a conserved basic region of 25 amino acids, located in the C-terminal part of the protein. Accordingly, synthetic p53-(357-381)-peptide is phosphorylated by PKC at multiple Ser and Thr residues, including Ser360, Thr365, Ser370 and Thr377. We also establish that p53-(357-381)-peptide at micromolar concentrations has the ability to stimulate sequence-specific DNA binding by p53. That stimulation is lost upon phosphorylation by PKC. To further characterise the mechanisms that regulate PKC-dependent phosphorylation of p53-(357-381)-peptide, the phosphorylation of recombinant p53 and p53-(357-381)-peptide by PKC were compared. The results suggest that phosphorylation of full-length p53 on the C-terminal PKC sites is highly dependent on the accessibility of the phosphorylation sites and that a domain on p53 distinct from p53-(357-381)-peptide is involved in binding PKC. Accordingly, we have identified a conserved 27-amino-acid peptide, p53-(320-346)-peptide, within the C-terminal region of p53 and adjacent to residues 357-381 that interacts with PKC in vitro. The interaction between p53-(320-346)-peptide and PKC inhibits PKC autophosphorylation and the phosphorylation of substrates, including p53-(357-381)-peptide, neurogranin and histone H1. Conventional Ca2+-dependent PKC alpha, beta and gamma and the catalytic fragment of PKC (PKM) were nearly equally susceptible to inhibition by p53-(320-346)-peptide. The Ca2+-independent PKC delta was much less sensitive to inhibition. The significance of these findings for understanding the in vivo phosphorylation of p53 by PKC are discussed.

Citing Articles

Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21(WAF1/CIP1) expression.

Ho D, Kim H, Kim J, Sim H, Ahn H, Kim J Mol Brain. 2015; 8:54.

PMID: 26384650 PMC: 4575451. DOI: 10.1186/s13041-015-0145-7.


Reduction of protein kinase C α (PKC-α) promote apoptosis via down-regulation of Dicer in bladder cancer.

Jiang Z, Kong C, Zhang Z, Zhu Y, Zhang Y, Chen X J Cell Mol Med. 2015; 19(5):1085-93.

PMID: 25752336 PMC: 4420610. DOI: 10.1111/jcmm.12503.


Allosteric modulation of protein oligomerization: an emerging approach to drug design.

Gabizon R, Friedler A Front Chem. 2014; 2:9.

PMID: 24790978 PMC: 3982530. DOI: 10.3389/fchem.2014.00009.


Role of p53 in Cell Death and Human Cancers.

Ozaki T, Nakagawara A Cancers (Basel). 2013; 3(1):994-1013.

PMID: 24212651 PMC: 3756401. DOI: 10.3390/cancers3010994.


Protein kinase Cα (PKCα) regulates p53 localization and melanoma cell survival downstream of integrin αv in three-dimensional collagen and in vivo.

Smith S, Enge M, Bao W, Thullberg M, Costa T, Olofsson H J Biol Chem. 2012; 287(35):29336-47.

PMID: 22773839 PMC: 3436133. DOI: 10.1074/jbc.M112.341917.